ViaCyte and CRISPR Introduce New Stem Cell Therapy for Type 1 Diabetes
CRISPR-Cas9 successfully reverses obesity in mice
CRISPR Therapeutics and ViaCyte Tackling Type 1 Diabetes - YouTube
Looking into the possibilities of cure of the type 2 diabetes mellitus by nanoparticle-based RNAi and CRISPR-Cas9 system: A review - ScienceDirect
A genome-wide CRISPR screen identifies regulators of beta cell function involved in type 2 diabetes risk | bioRxiv
News: First CRISPR Therapy for Type 1 Diabetes Set to Enter Clinical Trial - CRISPR Medicine
Interview: CRISPR and stem cells to cure diabetes - CRISPR Medicine
Frontiers | Functional Genomics in Pancreatic β Cells: Recent Advances in Gene Deletion and Genome Editing Technologies for Diabetes Research
Type-2 Diabetes and Gene Therapy: The Promise of CRISPR Gene Therapy in type-2 Diabetes Mellitus - Open Access Pub
Can CRISPR Therapeutics (CRSP) and ViaCyte CURE Type 1 Diabetes? | VCTX210 - YouTube
Target gene activation via CRISPR/Cas9 used to treat type 1 diabetes, muscular dystrophy, and acute kidney disease in mouse models : r/science
CRISPR/Cas9 system - a revolution in gene editing
Diabetology | Free Full-Text | Novel Insights into the Immunotherapy-Based Treatment Strategy for Autoimmune Type 1 Diabetes
CRISPR Therapeutics and ViaCyte, Inc. Announce First
Can CRISPR gene therapy help cure diabetes? - New West Physicians : New West Physicians | Healthcare Providers
CRISPR for Type 1 & 2 Diabetes Identification and Treatment | IDT
ActoBio's Cheese-Producing Bacteria Could Reverse Type 1 Diabetes
B.C. researchers launching clinical trial for first genetically engineered stem cell-based therapy for type 1 diabetes
Sweet Spot: CRISPR Therapeutics, ViaCyte Dose First Patient with Cell Therapy for Type 1 Diabetes
Modeling Type 1 Diabetes In Vitro Using Human Pluripotent Stem Cells - ScienceDirect
ViaCyte | Regenerative Medicine Therapies for Diabetes
Stem Cells and the Search For a Type 1 Diabetes Cure
Strategies for durable β cell replacement in type 1 diabetes | Science
New CRISPR/Cas9 Technique to Potentially Cure Type 1 Diabetes Mellitus - European Medical Journal
Frontiers | Stem Cell Transplantation in the Treatment of Type 1 Diabetes Mellitus: From Insulin Replacement to Beta-Cell Replacement
